BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17342647)

  • 1. Newest approaches to treatment of pelvic inflammatory disease: a review of recent randomized clinical trials.
    Haggerty CL; Ness RB
    Clin Infect Dis; 2007 Apr; 44(7):953-60. PubMed ID: 17342647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials.
    Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross JDC
    Sex Transm Infect; 2019 Feb; 95(1):21-27. PubMed ID: 30341232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients.
    Arredondo JL; Diaz V; Gaitan H; Maradiegue E; Oyarzún E; Paz R; Reynal JL; Stamm W; Zambrano D
    Clin Infect Dis; 1997 Feb; 24(2):170-8. PubMed ID: 9114143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose oral diclofenac for acute postoperative pain in adults.
    Derry P; Derry S; Moore RA; McQuay HJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004768. PubMed ID: 19370609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.
    Judlin P; Liao Q; Liu Z; Reimnitz P; Hampel B; Arvis P
    BJOG; 2010 Nov; 117(12):1475-84. PubMed ID: 20716255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study on clinical efficacy of ofloxacin in respiratory and urinary tract infections.
    Grassi GG
    Infection; 1986; 14 Suppl 4():S300-2. PubMed ID: 3546149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: a preliminary study.
    Judlin P; Thiebaugeorges O
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):177-9. PubMed ID: 19467767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic therapy for pelvic inflammatory disease.
    Savaris RF; Fuhrich DG; Duarte RV; Franik S; Ross J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010285. PubMed ID: 28436019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of pelvic examination in pelvic inflammatory disease: A meta-analysis.
    Iwata H; Sugiyama Y; Satoi Y; Sasamoto N; Aoki T; Matsushima M
    J Gen Fam Med; 2022 Nov; 23(6):384-392. PubMed ID: 36349207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding consumer preferences for care of adolescents with pelvic inflammatory disease.
    Trent M; Lehmann H; Butz A; Thompson C; Qian Q; Frick KD
    Med Ther Med Reprod Gynecol Endocrinol; 2013; 15(4):358-362. PubMed ID: 31131365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of Chlamydia trachomatis and Mycoplasma spp., but not Neisseria gonorrhoeae and Treponema pallidum, in women undergoing an infertility evaluation: high prevalence of tetracycline resistance gene tet(M).
    Li M; Zhang X; Huang K; Qiu H; Zhang J; Kang Y; Wang C
    AMB Express; 2017 Nov; 7(1):206. PubMed ID: 29150724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors.
    Nkuize M; De Wit S; Muls V; Delforge M; Miendje Deyi VY; Cadière GB; Buset M
    PLoS One; 2015; 10(12):e0145119. PubMed ID: 26691198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Pelvic Inflammatory Disease in Selected U.S. Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.
    Llata E; Bernstein KT; Kerani RP; Pathela P; Schwebke JR; Schumacher C; Stenger M; Weinstock HS
    Sex Transm Dis; 2015 Aug; 42(8):429-33. PubMed ID: 26165434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Mycoplasma acquisition in male HIV-1 infected patients: a multistage cross-sectional survey in Jiangsu, China.
    Chen LS; Wu JR; Wang B; Yang T; Yuan R; Zhao YY; Xu JS; Guo HX; Huan XP
    Epidemiol Infect; 2015 Nov; 143(15):3327-34. PubMed ID: 25792346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status of adolescent pelvic inflammatory disease management in the United States.
    Trent M
    Curr Opin Obstet Gynecol; 2013 Oct; 25(5):350-6. PubMed ID: 24018871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing a potential role of host Pannexin 1 during Chlamydia trachomatis infection.
    McKuen MJ; Dahl G; Fields KA
    PLoS One; 2013; 8(5):e63732. PubMed ID: 23700432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological survey of Mycoplasma hominis and Ureaplasma urealyticum in gynaecological outpatients, Rome, Italy.
    Verteramo R; Patella A; Calzolari E; Recine N; Marcone V; Osborn J; Chiarini F; Degener AM
    Epidemiol Infect; 2013 Dec; 141(12):2650-7. PubMed ID: 23445723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy.
    Cover NF; Lai-Yuen S; Parsons AK; Kumar A
    Int J Nanomedicine; 2012; 7():2411-9. PubMed ID: 22811601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moxifloxacin safety: an analysis of 14 years of clinical data.
    Tulkens PM; Arvis P; Kruesmann F
    Drugs R D; 2012 Jun; 12(2):71-100. PubMed ID: 22715866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.
    Sweet RL
    Curr Infect Dis Rep; 2012 Feb; ():. PubMed ID: 22298157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.